30-Jun-23 | 30-Jun-22 | 30-Jun-21 | 30-Jun-20 | 30-Jun-19 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Asia | 92.90 | 13% | 83.30 | 14% | 101.50 | 18% | 70.80 | 13% | 44.20 | 9% |
Latin America | 105.60 | 15% | 94.60 | 16% | 83.80 | 15% | 81.80 | 15% | 81.10 | 17% |
North America | 288.50 | 42% | 238.50 | 40% | 214.70 | 37% | 226.40 | 41% | 211.80 | 43% |
Rest of Europe, Middle East, Russia and Africa | 109.60 | 16% | 88.30 | 15% | 82.10 | 14% | 78.00 | 14% | 67.70 | 14% |
UK | 93.10 | 13% | 88.70 | 15% | 92.20 | 16% | 94.40 | 17% | 83.70 | 17% |
Total | 689.70 | 100% | 593.40 | 100% | 574.30 | 100% | 551.40 | 100% | 488.50 | 100% |
Profit Before Tax | ||||||||||
Unanalysed | 39.40 | 100% | 48.40 | 100% | 55.80 | 100% | 46.30 | 100% | 9.90 | 100% |
Total | 39.40 | 100% | 48.40 | 100% | 55.80 | 100% | 46.30 | 100% | 9.90 | 100% |
30-Jun-23 | 30-Jun-22 | 30-Jun-21 | 30-Jun-20 | 30-Jun-19 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Genus ABS | 318.80 | 46% | 272.00 | 46% | 250.10 | 44% | 237.60 | 43% | 222.60 | 46% |
Genus PIC | 349.50 | 51% | 306.60 | 52% | 315.60 | 55% | 298.80 | 54% | 253.70 | 52% |
Research and Development | 21.40 | 3% | 14.80 | 2% | 8.60 | 1% | 15.00 | 3% | 12.20 | 2% |
Total | 689.70 | 100% | 593.40 | 100% | 574.30 | 100% | 551.40 | 100% | 488.50 | 100% |
Profit Before Tax | ||||||||||
Genus ABS | n/a | n/a | n/a | n/a | n/a | n/a | 32.50 | n/a | 29.90 | n/a |
Genus PIC | n/a | n/a | n/a | n/a | n/a | n/a | 113.30 | n/a | 93.10 | n/a |
Research and Development | n/a | n/a | n/a | n/a | n/a | n/a | (64.90) | n/a | (54.40) | n/a |
Unanalysed | 39.40 | n/a | 48.40 | n/a | 55.80 | n/a | (34.60) | n/a | (58.70) | n/a |
Total | 39.40 | n/a | 48.40 | n/a | 55.80 | n/a | 46.30 | n/a | 9.90 | n/a |
You are here: research